SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus (SLE) Interventions: Drug: SG301 SC Injection Sponsors: Hangzhou Sumgen Biotech Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials